Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Live birth outcomes of vitrified embryos generated under growth hormone stimulation are improved for women categorized as poor-prognosis.

Keane KN, Ye Y, Hinchliffe PM, Regan SL, Dhaliwal SS, Yovich JL.

Clin Exp Reprod Med. 2019 Dec;46(4):178-188. doi: 10.5653/cerm.2019.00206. Epub 2019 Nov 19.

2.

The Evolving Concept of Poor-Prognosis for Women Undertaking IVF and the Notion of Growth Hormone as an Adjuvant; A Single-Center Viewpoint.

Yovich JL, Ye Y, Regan SLP, Keane KN.

Front Endocrinol (Lausanne). 2019 Nov 20;10:808. doi: 10.3389/fendo.2019.00808. eCollection 2019. Review.

3.

Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.

Toftager M, Bogstad J, Løssl K, Prætorius L, Zedeler A, Bryndorf T, Nilas L, Pinborg A.

Hum Reprod. 2017 Mar 1;32(3):556-567. doi: 10.1093/humrep/dew358.

PMID:
28130435
4.

Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?

Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP.

Hum Reprod. 2016 Feb;31(2):370-6. doi: 10.1093/humrep/dev316. Epub 2016 Jan 2.

PMID:
26724797
5.

DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis.

Keane KN, Hinchliffe PM, Rowlands PK, Borude G, Srinivasan S, Dhaliwal SS, Yovich JL.

Front Endocrinol (Lausanne). 2018 Jan 31;9:14. doi: 10.3389/fendo.2018.00014. eCollection 2018.

6.

Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis.

Keane KN, Yovich JL, Hamidi A, Hinchliffe PM, Dhaliwal SS.

BMJ Open. 2017 Oct 8;7(10):e018107. doi: 10.1136/bmjopen-2017-018107.

7.

Elective single embryo transfer following in vitro fertilization.

Min JK, Hughes E, Young D; JOINT SOGC-CFAS CLINICAL PRACTICE GUIDELINES COMMITTEE; REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY COMMITTEE.

J Obstet Gynaecol Can. 2010 Apr;32(4):363-377. doi: 10.1016/S1701-2163(16)34482-6.

PMID:
20500945
8.

Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.

JOINT SOGC-CFAS.

Int J Gynaecol Obstet. 2008 Aug;102(2):203-16. Review.

PMID:
18773532
9.

Looking past the appearance: a comprehensive description of the clinical contribution of poor-quality blastocysts to increase live birth rates during cycles with aneuploidy testing.

Cimadomo D, Soscia D, Vaiarelli A, Maggiulli R, Capalbo A, Ubaldi FM, Rienzi L.

Hum Reprod. 2019 Jul 8;34(7):1206-1214. doi: 10.1093/humrep/dez078.

PMID:
31247100
10.

In vitro fertilization and multiple pregnancies: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2006;6(18):1-63. Epub 2006 Oct 1.

11.

High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers.

Munch EM, Sparks AE, Zimmerman MB, Van Voorhis BJ, Duran EH.

Hum Reprod. 2017 Jul 1;32(7):1402-1409. doi: 10.1093/humrep/dex094.

PMID:
28472321
12.

Effects of growth hormone plus gonadotropins on controlled ovarian stimulation in infertile women of advanced age, poor responders, and previous in vitro fertilization failure patients.

Ho YK, Lee TH, Lee CI, Cheng EH, Huang CC, Huang LS, Lee MS.

Taiwan J Obstet Gynecol. 2017 Dec;56(6):806-810. doi: 10.1016/j.tjog.2017.10.018.

13.

Fresh transfer of Day 5 slow-growing embryos versus deferred transfer of vitrified, fully expanded Day 6 blastocysts: which is the optimal approach?

Tannus S, Cohen Y, Henderson S, Al Ma'mari N, Shavit T, Son WY, Dahan MH.

Hum Reprod. 2019 Jan 1;34(1):44-51. doi: 10.1093/humrep/dey351.

PMID:
30517719
14.

Use of ICSI in IVF cycles in women with tubal ligation does not improve pregnancy or live birth rates.

Grimstad FW, Nangia AK, Luke B, Stern JE, Mak W.

Hum Reprod. 2016 Dec;31(12):2750-2755. Epub 2016 Oct 13.

15.

In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes.

Walls ML, Hunter T, Ryan JP, Keelan JA, Nathan E, Hart RJ.

Hum Reprod. 2015 Jan;30(1):88-96. doi: 10.1093/humrep/deu248. Epub 2014 Oct 29.

PMID:
25355587
16.

Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.

Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ.

Fertil Steril. 2016 Feb;105(2):459-66.e2. doi: 10.1016/j.fertnstert.2015.10.026. Epub 2015 Nov 18.

PMID:
26604065
17.

A comparison of live birth rates and perinatal outcomes between cryopreserved oocytes and cryopreserved embryos.

Ho JR, Woo I, Louie K, Salem W, Jabara SI, Bendikson KA, Paulson RJ, Chung K.

J Assist Reprod Genet. 2017 Oct;34(10):1359-1366. doi: 10.1007/s10815-017-0995-2. Epub 2017 Jul 17.

18.

Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF.

Yovich JL, Stanger JD.

Reprod Biomed Online. 2010 Jul;21(1):37-49. doi: 10.1016/j.rbmo.2010.03.013. Epub 2010 Apr 2. Erratum in: Reprod Biomed Online. 2011 Jan;22(1):100.

PMID:
20457541
19.
20.

The correlation between basal serum follicle-stimulating hormone levels before embryo cryopreservation and the clinical outcome of frozen embryo transfers.

Kassab A, Sabatini L, Tozer A, Zosmer A, Mostafa M, Al-Shawaf T.

Fertil Steril. 2009 Oct;92(4):1269-75. doi: 10.1016/j.fertnstert.2008.08.077. Epub 2008 Oct 17.

PMID:
18930194

Supplemental Content

Support Center